APH Form 4/A Corrects Trust Ownership; 76,400 Shares Disposed
Rhea-AI Filing Summary
Amended Form 4 for APH reporting correction to prior insider filing. The filing shows that on 08/18/2025 the reporting person disposed of 76,400 shares of Class A common stock. Following the reported transactions the reporting person beneficially owns 25,000 shares indirectly through a 2025 GRAT #1 and 0 shares indirectly through a 2024 Irrevocable Trust. The amendment states a previously filed Form 4 (filed 08/19/2025) incorrectly reported that the 2024 Irrevocable Trust beneficially owned non-derivative securities; this amendment corrects the beneficial ownership amounts. The form is signed by Lance E. D'Amico and identifies his role as Sr. VP, Secretary & General Counsel of Amphenol Corporation.
Positive
- Amendment filed to correct prior error, improving disclosure accuracy
- Post-transaction beneficial ownership clarified (25,000 shares held indirectly in 2025 GRAT #1)
Negative
- Insider disposed of 76,400 Class A shares on 08/18/2025 (sale reduces direct holdings)
- Prior Form 4 misreported beneficial ownership for the 2024 Irrevocable Trust, indicating a reporting lapse
Insights
TL;DR: Amendment corrects prior reporting and discloses an insider disposal of 76,400 shares; impact appears procedural and not immediately material to operations.
The amended Form 4 clarifies beneficial ownership after a sale on 08/18/2025 and removes an erroneous attribution to a 2024 Irrevocable Trust. The direct disposal of 76,400 Class A shares reduces the reporting person's direct stake; however, without price or percentage of outstanding shares the market-cap impact cannot be assessed from this filing alone. The correction improves disclosure accuracy, which is important for governance and market transparency.
TL;DR: Correction indicates a prior reporting error; filing the amendment is a positive compliance step but highlights a lapse in initial reporting accuracy.
The amendment explicitly states the initial Form 4 misattributed non-derivative holdings to the 2024 Irrevocable Trust and now provides the corrected post-transaction ownership figures. Timely amendment reduces regulatory risk, but the initial misstatement is a governance concern that investors monitoring insider reporting practices may note. No new derivative instruments or compensatory grants are disclosed.
FAQ
What did the amended Form 4 for Amphenol (APH) change?
How many shares did the reporting person dispose of and when?
What beneficial ownership remains after the reported transactions?
Who is the reporting person and what is their role at Amphenol?
Does the amendment disclose any derivative transactions or new grants?